Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

Objective To identify predictors of response to methotrexate (MTX) in early rheumatoid arthritis (RA). Methods In the SWEFOT trial, patients with RA with symptom duration

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2011-03, Vol.70 (3), p.469-475
Hauptverfasser:	Saevarsdottir, Saedis, Wallin, Helena, Seddighzadeh, Maria, Ernestam, Sofia, Geborek, Pierre, Petersson, Ingemar F, Bratt, Johan, van Vollenhoven, Ronald F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Clinical Medicine Diseases of the osteoarticular system Drug dosages Drug Therapy, Combination Epidemiologic Methods Female Glucocorticoids - therapeutic use Humans Immunosuppressive Agents - therapeutic use Inflammatory joint diseases Klinisk medicin Male Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Methotrexate - therapeutic use Middle Aged Pharmacology. Drug treatments Prednisolone - therapeutic use Prognosis Regression analysis Remission Induction Reumatologi och inflammation Rheumatism Rheumatoid arthritis Rheumatology Rheumatology and Autoimmunity Sensitivity analysis Sex Factors Smoking Smoking - adverse effects Statistical analysis TNF inhibitors Treatment Outcome Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective To identify predictors of response to methotrexate (MTX) in early rheumatoid arthritis (RA). Methods In the SWEFOT trial, patients with RA with symptom duration
ISSN:	0003-4967 1468-2060 1468-2060
DOI:	10.1136/ard.2010.139212